ArticleLife (Basel, Switzerland)2026

Resveratrol as a Dual MAPK/STAT3 Inhibitor in Glioblastoma: Mutation-Dependent Therapeutic Efficacy.

Aziz Ullah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.